Literature DB >> 10518229

Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.

I den Tonkelaar1, B J Oddens.   

Abstract

This study addresses attitudes towards changes in menstrual bleeding patterns caused by oral contraceptives (OC) or hormone replacement therapy (HRT) and preferred changes in bleeding pattern with and without use of OC or HRT in relation to reproductive age group. Data were collected by means of telephone interviews with 325 women in each of four age groups (15-19, 25-34, 45-49, and 52-57 years). In total, 80.5% of currently menstruating women preferred one or more changes in bleeding pattern such as less painful, shorter, or less heavy periods, or amenorrhea. The majority of the menstruating women in all age groups preferred to have a bleeding frequency of less than once a month or never, whether the bleeding was spontaneous or induced by OC. In the case of HRT, amenorrhea was most preferred. These findings with respect to preferred bleeding frequency and OC may have important implications for health care providers and for future contraception development.

Entities:  

Keywords:  Amenorrhea; Bleeding; Contraception; Contraceptive Methods; Developed Countries; Diseases; Europe; Family Planning; Health; Hormone Replacement Therapy; Menstruation; Menstruation Disorders; Netherlands; Oral Contraceptives; Reproduction; Reproductive Health; Research Report; Signs And Symptoms; Treatment; Western Europe

Mesh:

Substances:

Year:  1999        PMID: 10518229     DOI: 10.1016/s0010-7824(99)00043-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  18 in total

1.  Menstrual-related attitudes and symptoms among multi-racial Asian adolescent females.

Authors:  Li Ping Wong; Ee Ming Khoo
Journal:  Int J Behav Med       Date:  2010-05-04

2.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Long-cycle treatment with oral contraceptives.

Authors:  Inka Wiegratz; Herbert Kuhl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Situational and relational factors associated with coitus during vaginal bleeding among adolescent women.

Authors:  Devon J Hensel; J Dennis Fortenberry; Donald P Orr
Journal:  J Sex Res       Date:  2007-08

5.  Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students.

Authors:  Hannah Lakehomer; Paul F Kaplan; David G Wozniak; Christopher T Minson
Journal:  Contraception       Date:  2013-01-08       Impact factor: 3.375

6.  Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.

Authors:  Manuela Mejia; Colleen McNicholas; Tessa Madden; Jeffrey F Peipert
Journal:  Contraception       Date:  2016-06-27       Impact factor: 3.375

Review 7.  Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.

Authors:  Alison Edelman; Elizabeth Micks; Maria F Gallo; Jeffrey T Jensen; David A Grimes
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

8.  Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study.

Authors:  Christine Klipping; Ingrid Duijkers; Michel P Fortier; Joachim Marr; Dietmar Trummer; Jörg Elliesen
Journal:  J Fam Plann Reprod Health Care       Date:  2012-04

9.  Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives.

Authors:  Giuseppe Benagiano; Sabina Carrara; Valentina Filippi
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

10.  Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study.

Authors:  Stefanie Reif; Nelleke Snelder; Hartmut Blode
Journal:  J Fam Plann Reprod Health Care       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.